BSECentuple Global Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Mon, 22 Sept, 2025 · 15:03 IST

Outcome of Postal Ballot

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-2.0%Reaction day
₹44.30
prior close
₹43.42
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.7%-1.2% vs market
Pharmaceuticals peers, median of 153sector-1.0%-0.9% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-2.0-0.7-1.2-1.0-0.9
Next day
-0.0-1.0+1.0-1.3+1.2
2d
+1.9-1.4+3.3-1.5+3.5
3d
+4.0-2.4+6.4-2.3+6.2
4d
+6.0-4.5+10.5-4.2+10.2
5d
+8.1-5.3+13.4-4.6+12.7
1w
+12.5-4.3+16.8-3.2+15.6
15d
+31.6-4.6+36.3-4.9+36.5
1m
+36.8-2.2+39.0-4.2+41.0
2m
+107.0-5.6+112.6-7.5+114.6
3m
+136.7-6.6+143.3-7.3+144.0
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Checkpoint Trends Limited (Scrip Code: 531099) conducted a postal ballot via e-voting between August 21 and September 20, 2025, and declared results on September 22, 2025. Two resolutions were put to shareholders: (1) an Ordinary Resolution to increase the authorised share capital and amend the capital clause of the Memorandum of Association, and (2) a Special Resolution to add new objects to the Object Clause of the MoA. Both resolutions were passed with overwhelming support — 99.93% of votes polled were in favour (5,87,770 votes in favour vs. 420 against out of 5,88,190 shares polled). Only Public Non-Institutional shareholders participated in voting, with about 10.76% of total outstanding shares being polled.

Likely market impact

The approved increase in authorised share capital provides the company flexibility to issue more shares in the future (potentially for fundraising, expansion or acquisitions), while the broadened Object Clause allows it to enter new lines of business. Neither resolution is dilutive on its own, but shareholders should watch for follow-up announcements on any actual share issuance or new business plans. Note: very low voting turnout (~10.76%) and zero promoter participation in voting is unusual to highlight.